Skip to main content

Day: November 22, 2021

SFIO Acquires PH-based Tech and Software Development Hub LNS+ to Establish Global, Cross-Industry Innovation Ecosystem

The acquisition brings a full suite of tech platform development and maintenance capacities to the asset management companies; As part of SFIO’s investment roadmap into future-oriented industries, establishing LEENTech Network Systems as the group’s new Technology and Software Development division creates new avenues for collaborative innovation across SFIO’s diverse portfolio of companies NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) — Earlier this week, OTC:SFIO Starfleet Innotech, Inc. (Smokefree Innotec, Inc.) announced its acquisition of Philippine-based software development company LEENTech Network Solutions (LNS+), marking the asset management company’s new direction towards technology development. With LNS+ and its subsidiaries now onboard, SFIO is formalizing the team into their new Technology and Software Development Division. According...

Continue reading

Vivos Inc Announces John Hopkins University as a New Regional Clinic for Isopet®

Richland WA, Nov. 22, 2021 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that John Hopkins University Center for Image Guided Animal Therapy (CIGAT) is now an Isopet® regional clinic. Additionally, Johns Hopkins will also perform new Isopet® animal studies on various specific cancers. They have the required radioactive material license and have completed their training certification for Isopet®. Dr. Mike Korenko stated, “Our business plan is to establish new IsoPet® regional centers across the United States and then internationally. John Hopkins University has an excellent reputation and we are excited to add Johns Hopkins as an Isopet® regional clinic. This important relationship will also help meet our objective of obtaining high quality data on a range of cancers that can be published in leading journals....

Continue reading

8i Acquisition 2 Corp. Announces Pricing of $75 Million Initial Public Offering

Singapore, Nov. 22, 2021 (GLOBE NEWSWIRE) — 8i Acquisition 2 Corp. (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company and led by Chief Executive Officer, Meng Dong (James) Tan, today announced the pricing of its initial public offering of 7,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth (1/10) of an ordinary share. Each whole warrant will entitle the holder thereof to purchase purchase one-half (1/2) of one ordinary share, and each ten rights entitle the holder thereof to receive one ordinary share. The exercise price of the warrants is $11.50 per full share. The units are expected to trade on the Nasdaq Global Market, (“Nasdaq”) under the ticker symbol...

Continue reading

LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THAT ENROLLMENT HAS RESUMED IN NATIONAL CANCER INSTITUTE’S TRIAL TO DETERMINE ABILITY OF LIXTE COMPOUND LB-100 TO ENTER RECURRENT, MALIGNANT BRAIN TUMORS

PASADENA, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated. After enrolling two patients in the study, enrollment was suspended in 2020 due to COVID-19 restrictions. Those restrictions have now been lifted and patient recruitment has resumed (Clinical trials registry NCT03027388). Up to 20 patients may be enrolled to obtain 8 evaluable subjects. A two-stage design will be used. Five patients will be initially treated. If at least 1 of 5 demonstrates the presence of LB-100 in tumor tissue, 3 additional...

Continue reading

NSAV ANNOUNCES DECEMBER 6, 2021 LAUNCH DATE FOR PRIVATE SALE OF ITS NSAVDEX NATIVE TOKEN, THE NSBC, AND ENTRY INTO MULTI-BILLION DOLLAR MARKET

London, England, Nov. 22, 2021 (GLOBE NEWSWIRE) — Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced that the Private Sale of its NSAVDEX Native Token (NSBC) will commence on December 6, 2021 at 11:00 AM EST. The Company has set aside 10 million NSBC tokens for the private sale at 0.10 USDT per token. The NSBC (NSAV Blockchain) is the native token for the recently launched NSAVDEX Decentralized Cryptocurrency Exchange https://nsavdex.org/#/home . An NSAV shareholder conference call will be announced in the coming days to inform shareholders of the financial and technical aspects of the NSBC token and private sale. For further information, please contact the Company on our official DEX Telegram at https://t.me/NSAVDEXorg . The NSAVDEX native token will be using...

Continue reading

Crackle Original Series ‘Outbreak’ Premieres December 1st

10-part limited series follows a government agency and its attempts to fight an outbreak of a viral epidemic COS COB, Conn., Nov. 22, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (“the Company”) (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, announced today that the Crackle Original Series Outbreak will premiere on December 1. The 10-part limited series follows the interconnected stories and lives of seemingly complete strangers as their world becomes engulfed with a virus epidemic outbreak. The heart-pounding series, a French-Canadian production filmed in Montreal and Quebec, focuses on how the threat takes hold of the population, bringing out the best and the worst in people, calling forth a blend of paranoia, credulity, greed, self-sacrifice...

Continue reading

Matterport Announces Successful Completion of SOC 2 Type II Audit

Company ensures strict compliance in security and privacy for spatial data platform customers SUNNYVALE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR), the leading spatial data company driving the digital transformation of the built world, today announced it has successfully completed a SOC 2 Type II Service Organization Control (SOC 2) audit for its platform and services. Performed by independent Certified Public Accountant (CPA) firm, Frank, Rimerman + Co. LLP, the audit provides an objective evaluation of the effectiveness of controls involving operations and compliance at Matterport. Created by the American Institute of Certified Public Accountants (AICPA), SOC2 is a reporting framework that sets benchmarks for managing customer data. The completion of the SOC 2 Type II audit attests Matterport’s...

Continue reading

Triumph Bancorp Appoints Renee Galitis as Chief Information Officer

DALLAS, Nov. 22, 2021 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (Nasdaq: TBK) announced today the appointment of Renee Galitis as chief information officer. In her role, Galitis will execute the information technology (IT) strategy driving innovation and operational excellence for the company. She will provide direction and oversight for the IT and information security teams, leading existing and emerging technology initiatives. “Renee’s ability to align operational execution and technology transformation makes her an excellent fit for Triumph,” said Aaron P. Graft, chief executive officer. “Her experience leading large, complex projects and technology environments will be instrumental in taking our IT organization to the next level of transformation.” Galitis comes to Triumph with a successful track record of working for high-growth...

Continue reading

BioCorRx Acquires Intellectual Property for Drug Delivery

Patent Application Covers Solid Implant Formulation for Drug Delivery ANAHEIM, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that the Company has acquired a patent application from Calista Therapeutics. The current application, 17/465,748, was filed with the U.S. Patent and Trademark Office (USPTO) covering solid implant formulation for drug delivery. This IP complements the Company’s current IP portfolio and may be used for improvements to current naltrexone formulations owned by the Company or licensed to third parties for use with other molecules where solid implant formulations are desired. Lourdes Felix, CEO, CFO and Director of BioCorRx Inc., stated, “We...

Continue reading

PLx Pharma Inc. to Present at Piper Sandler 33rd Annual Healthcare Conference 2021

SPARTA, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORE™ 325 mg and VAZALORE™ 81 mg liquid-filled aspirin capsules (referred to together as “VAZALORE”), announced today that Natasha Giordano, President and Chief Executive Officer, and Rita O’Connor, Chief Financial Officer, are scheduled to present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021.Date: Monday, November 22, 2021Time/On Demand: 10:00 a.m. ETWebcast: https://pipersandler.zoom.us/rec/play/sDoWhmNTPTcs-2ryqdNstA_8p5szMRwpYCiZ4yZZ0mPqzpGwYIvCugpdxgKdwx_QnBUDg8_x68njBqIt.X5bELQj2jSVlI0U3The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.